4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001702031-26-000002
SVP, Business Development sold 42,431 shares at $8.27 ($350,730)
From the SEC's structured data for this filing
Trades in this filing
Birznieks Gunther · SVP, Business Development
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-02 | Sale : show line 1 in the form | −42,431 | $8.27 | $350,730 | 494,197 | D |
| Open-market sales · 42,431 sh · avg $8.27 · $350,730 | ||||||
Loading xslF345X05/ownership.xml…